1976
DOI: 10.1007/bf01990188
|View full text |Cite
|
Sign up to set email alerts
|

Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540)

Abstract: A procedure to enhance the schistosomicidal effectiveness in vivo of an isothiocyanate derivative and some of its antischistosomal properties are reported. Determinations of the effects of this compound on tissue thiol levels and on highly sensitivity bacterial tester strains have indicated that its mutagenic potential is of a low order and that the latter is decreased further after reduction of the host's intestinal bacterial flora.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
12
0
1

Year Published

1978
1978
2012
2012

Publication Types

Select...
4
4
1

Relationship

1
8

Authors

Journals

citations
Cited by 47 publications
(14 citation statements)
references
References 12 publications
1
12
0
1
Order By: Relevance
“…This antischistosomal compound is not mutagenic in vitro to Ames tester strain TAtOO even in the presence of microsomal preparations, but mutagenesis occurs with the tester strain in the mouse peritoneum (69). Metabolic activity by the flora may explain this observation since mutagenic activity in mouse urine after feeding 4-isothiocyanat0-4'-nitrodiphenyla mine is markedly decreased by prior treatment with succinylsulfathiazole.…”
Section: The Further Study Of This Problemmentioning
confidence: 92%
“…This antischistosomal compound is not mutagenic in vitro to Ames tester strain TAtOO even in the presence of microsomal preparations, but mutagenesis occurs with the tester strain in the mouse peritoneum (69). Metabolic activity by the flora may explain this observation since mutagenic activity in mouse urine after feeding 4-isothiocyanat0-4'-nitrodiphenyla mine is markedly decreased by prior treatment with succinylsulfathiazole.…”
Section: The Further Study Of This Problemmentioning
confidence: 92%
“…Treatment of mice infected with Schistosoma mansoni with CS-A was at least additive to the effects of subcurative doses of amoscanate, a new potent antischistosomal drug [11,12] (Table 2). Therefore, it appears that the actions of the two compounds on the parasites are synergistic with each other.…”
Section: Methodsmentioning
confidence: 99%
“…In 1976, Striebel described the use of amoscanate (4-isothiocyanato-4'-nitrodiphenylamine) against helminthic diseases. At that time its wide activity range was confirmed, as it was used against most Schistosoma species, filariae and gastrointestinal nematodes (Bueding et al, 1976). Amoscanate was tested in humans infected with S. japonicum, and the cure rates were as high as 92%.…”
Section: Chemotherapy Against Schistosomiasismentioning
confidence: 96%